Position in CELC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,035,465
+$117,173 QoQ
Shares Held
48,131
+11.7% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 274 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,525,193 across 328 Biotechnology names. CELC ranks #48 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in CELC
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,035,465 | 48,131 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,918,292 | 43,090 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,800,492 | 38,104 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,047,136 | 41,440 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $570,004 | 42,697 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $426,581 | 42,194 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $507,302 | 38,755 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $479,058 | 32,130 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $531,760 | 32,464 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $548,964 | 25,415 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $340,952 | 23,401 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $187,123 | 20,473 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $216,953 | 19,759 | Shares | Sole | 2023-08-08 | |
| No filing history on record for this holder in this stock. | ||||||